Literature DB >> 34935863

Winter of Omicron-The Evolving COVID-19 Pandemic.

Carlos Del Rio1, Saad B Omer2, Preeti N Malani3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 34935863     DOI： 10.1001/jama.2021.24315

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  57 in total

Review 1.  An insight into SARS-CoV-2 structure, pathogenesis, target hunting for drug development and vaccine initiatives.

Authors:  Arijit Ghosh; Paritosh K Kar; Anupam Gautam; Rahul Gupta; Rajveer Singh; Rudra Chakravarti; Velayutham Ravichandiran; Shubhra Ghosh Dastidar; Dipanjan Ghosh; Syamal Roy
Journal:  RSC Med Chem       Date:  2022-01-25

2.  Pre-Impressions of the Third COVID-19 Vaccination among Medical Staff: A Text Mining-Based Survey.

Authors:  Yoshiro Mori; Nobuyuki Miyatake; Hiromi Suzuki; Yuka Mori; Setsuo Okada; Kiyotaka Tanimoto
Journal:  Vaccines (Basel)       Date:  2022-05-26

Review 3.  Acute and Long-Term Consequences of COVID-19 on Arterial Stiffness-A Narrative Review.

Authors:  Ioana Mădălina Zota; Cristian Stătescu; Radu Andy Sascău; Mihai Roca; Larisa Anghel; Alexandra Maștaleru; Maria Magdalena Leon-Constantin; Cristina Mihaela Ghiciuc; Sebastian Romica Cozma; Lucia Corina Dima-Cozma; Irina Mihaela Esanu; Florin Mitu
Journal:  Life (Basel)       Date:  2022-05-25

4.  Scientific and Folk Theories of Viral Transmission: A Comparison of COVID-19 and the Common Cold.

Authors:  Danielle Labotka; Susan A Gelman
Journal:  Front Psychol       Date:  2022-06-28

Review 5.  Pathogenic Mechanism and Multi-omics Analysis of Oral Manifestations in COVID-19.

Authors:  Ming Hao; Dongxu Wang; Qianyun Xia; Shaoning Kan; Lu Chang; Huimin Liu; Zhijing Yang; Weiwei Liu
Journal:  Front Immunol       Date:  2022-07-04       Impact factor: 8.786

6.  Immunogenic dynamics and SARS-CoV-2 variant neutralisation of the heterologous ChAdOx1-S/BNT162b2 vaccination: Secondary analysis of the randomised CombiVacS study.

Authors:  Javier García-Pérez; María González-Pérez; María Castillo de la Osa; Alberto M Borobia; Luis Castaño; María Jesús Bertrán; Magdalena Campins; Antonio Portolés; David Lora; Mercedes Bermejo; Patricia Conde; Lourdes Hernández-Gutierrez; Antonio Carcas; Eunate Arana-Arri; Marta Tortajada; Inmaculada Fuentes; Ana Ascaso; María Teresa García-Morales; Humberto Erick de la Torre-Tarazona; José-Ramón Arribas; Natale Imaz-Ayo; Eugènia Mellado-Pau; Antonia Agustí; Carla Pérez-Ingidua; Agustín Gómez de la Cámara; Jordi Ochando; Cristobal Belda-Iniesta; Jesús Frías; José Alcamí; Mayte Pérez-Olmeda
Journal:  EClinicalMedicine       Date:  2022-07-01

Review 7.  Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants.

Authors:  Cong Sun; Chu Xie; Guo-Long Bu; Lan-Yi Zhong; Mu-Sheng Zeng
Journal:  Signal Transduct Target Ther       Date:  2022-06-28

8.  SARS-CoV-2 wastewater monitoring using a novel PCR-based method rapidly captured the Delta-to-Omicron ΒΑ.1 transition patterns in the absence of conventional surveillance evidence.

Authors:  Taxiarchis Chassalevris; Serafeim C Chaintoutis; Michalis Koureas; Maria Petala; Evangelia Moutou; Christina Beta; Maria Kyritsi; Christos Hadjichristodoulou; Margaritis Kostoglou; Thodoris Karapantsios; Agis Papadopoulos; Nikolaos Papaioannou; Chrysostomos I Dovas
Journal:  Sci Total Environ       Date:  2022-06-24       Impact factor: 10.753

Review 9.  The SARS-CoV-2 main protease (Mpro): Structure, function, and emerging therapies for COVID-19.

Authors:  Qing Hu; Yuan Xiong; Guang-Hao Zhu; Ya-Ni Zhang; Yi-Wen Zhang; Ping Huang; Guang-Bo Ge
Journal:  MedComm (2020)       Date:  2022-07-14

10.  Treatment delay and outcomes of ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention during the COVID-19 era in South Korea.

Authors:  Seok Oh; Myung Ho Jeong; Kyung Hoon Cho; Min Chul Kim; Doo Sun Sim; Young Joon Hong; Ju Han Kim; Youngkeun Ahn
Journal:  Korean J Intern Med       Date:  2022-06-28       Impact factor: 3.165
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.